Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CDM Insights

K-Number: K240680 · 2024-12-06

Decision Date2024-12-06
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CDM Insights is the device name listed in this FDA 510(k) record. The listed applicant is Oxford Brain Diagnostics, Ltd.. It received FDA 510(k) clearance on 2024-12-06 under 510(k) number K240680. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CDM Insights?

CDM Insights is a medical device that received FDA 510(k) clearance on 2024-12-06. The listed applicant is Oxford Brain Diagnostics, Ltd.. The 510(k) number is K240680.

When did CDM Insights receive FDA 510(k) clearance?

CDM Insights received FDA 510(k) clearance on 2024-12-06, under 510(k) number K240680.

Who is the listed applicant for CDM Insights?

The FDA 510(k) record lists Oxford Brain Diagnostics, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CDM Insights?

The FDA product code for CDM Insights is QIH.

Related Devices (Code: QIH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.